These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13756040)

  • 21. Some quantitative aspects of passive anaphylaxis in pertussis-vaccinated mice.
    PITTMAN M; GERMUTH FG
    Proc Soc Exp Biol Med; 1954 Nov; 87(2):425-8. PubMed ID: 13237263
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization.
    Rubin K; Glazer S
    Med Hypotheses; 2018 Nov; 120():101-115. PubMed ID: 30220328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of Bordetella pertussis on the lymphatic tissue of mice. VII. Studies on the relationships between the various biological effects induced by Bordetella pertussis].
    Finger H; Stein P; Beneke G; Emmerling P; Plager L
    Med Microbiol Immunol; 1972; 157(4):265-90. PubMed ID: 4343422
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaphylaxis in Bordetella pertussis-treated mice. III. Passive cutaneous anaphylaxis.
    MUNOZ J; ANACKER RL
    J Immunol; 1959 Dec; 83():640-4. PubMed ID: 14425264
    [No Abstract]   [Full Text] [Related]  

  • 26. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
    Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
    Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE MECHANISM OF ANAPHYLAXIS. II. THE ROLE OF 'MAST CELL SENSITIZING' ANTIBODY AND DELAYED HYPERSENSITIVITY IN RAT ANAPHYLAXIS.
    MOTA I
    Immunology; 1964 Nov; 7(6):700-6. PubMed ID: 14239844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effects of vaccines against Bordetella parapertussis in a mouse intranasal challenge model.
    Komatsu E; Yamaguchi F; Eguchi M; Watanabe M
    Vaccine; 2010 Jun; 28(27):4362-8. PubMed ID: 20438876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaphylactic shock in the mouse vaccinated with Hemophilus pertussis. IV. Studies on the adrenal gland.
    MALKIEL S
    J Allergy; 1956 Sep; 27(5):445-9. PubMed ID: 13357235
    [No Abstract]   [Full Text] [Related]  

  • 30. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Experimental whooping cough of nonhuman primate].
    Kubrava DT; Medkova AIu; Siniashina LN; Shevtsova ZV; Matua AZ; Kondzharia IG; Barkaia VS; Elistratova ZhV; Karataev GI; Mikvabia ZIa; Gintsburg AL
    Vestn Ross Akad Med Nauk; 2013; (8):28-33. PubMed ID: 24340642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anaphylaxis in Bordetella pertussis-treated mice. II. Passive anaphylaxis with homologous antibody.
    MUNOZ J; ANACKER RL
    J Immunol; 1959 Nov; 83():502-6. PubMed ID: 14425263
    [No Abstract]   [Full Text] [Related]  

  • 33. IMMUNE RABBIT SERUM AGAINST EXPERIMENTAL MURINE INFECTION WITH BORDETELLA PERTUSSIS.
    LIN TM
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1965 Mar; 64():134-7. PubMed ID: 14315140
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B; Douce G; Baillie S; Parton R; Coote J
    Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bordetella pertussis: why is it still circulating?
    Guiso N
    J Infect; 2014 Jan; 68 Suppl 1():S119-24. PubMed ID: 24103807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surveillance of pertussis: methods and implementation.
    Guiso N; Wirsing von König CH
    Expert Rev Anti Infect Ther; 2016 Jul; 14(7):657-67. PubMed ID: 27224518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roads to the development of improved pertussis vaccines paved by immunology.
    Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH
    Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.
    Knight JB; Huang YY; Halperin SA; Anderson R; Morris A; Macmillan A; Jones T; Burt DS; Van Nest G; Lee SF
    Clin Exp Immunol; 2006 Jun; 144(3):543-51. PubMed ID: 16734625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.